within Pharmacolibrary.Drugs.ATC.V;

model V08AB10
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00175,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0161,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0050999999999999995,
    k12             = 0.17,
    k21             = 0.17
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V08AB10</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Iomeprol is a non-ionic, low-osmolar iodinated contrast medium used in diagnostic imaging procedures such as computed tomography (CT) scans and angiography to enhance the visibility of vascular structures and organs. It is approved for use in many countries for these purposes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult subjects after intravenous bolus administration.</p><h4>References</h4><ol><li><p>Rosati, G (1994). Clinical pharmacology of iomeprol. <i>European journal of radiology</i> 18 Suppl 1 S51–S60. DOI:<a href=&quot;https://doi.org/10.1016/0720-048x(94)90094-9&quot;>10.1016/0720-048x(94)90094-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8020519/&quot;>https://pubmed.ncbi.nlm.nih.gov/8020519</a></p></li><li><p>Lorusso, V, et al., &amp; Spinazzi, A (2001). Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis. <i>Investigative radiology</i> 36(6) 309–316. DOI:<a href=&quot;https://doi.org/10.1097/00004424-200106000-00002&quot;>10.1097/00004424-200106000-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11410750/&quot;>https://pubmed.ncbi.nlm.nih.gov/11410750</a></p></li><li><p>Lorusso, V, et al., &amp; de Haën, C (1994). Pharmacokinetics and tissue distribution of iomeprol in animals. <i>European journal of radiology</i> 18 Suppl 1 S13–S20. DOI:<a href=&quot;https://doi.org/10.1016/0720-048x(94)90090-6&quot;>10.1016/0720-048x(94)90090-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8020515/&quot;>https://pubmed.ncbi.nlm.nih.gov/8020515</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V08AB10;
